Sumanta Pal, M.D.

City of Hope National Medical Center
email: spal@coh.org

Grants

Survival in de novo and Recurrent Metastatic Breast Cancer 2009 (Cycle 15)
IDEA (Innovative, Developmental, and Exploratory Awards) 15IB-0140 $249,000


Male breast cancer: an update in diagnosis, treatment and molecular profiling.
  Periodical: Maturitas
  Author(s): Onami S, Ozaki M, Mortimer JE, Pal SK
  Yr: 2010 Vol: 65 Nbr: 4 Pgs: 308-14
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Evaluating the older patient with cancer: understanding frailty and the geriatric assessment.
  Periodical: CA: A Cancer Journal for Clinicians
  Author(s): Pal SK, Katheria V, Hurria A
  Yr: 2010 Vol: 60 Nbr: 2 Pgs: 120-32
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Papillary carcinoma of the breast: an overview.
  Periodical: Breast Cancer Research and Treatment
  Author(s): Pal SK, Lau SK, Kruper L, et al.
  Yr: 2010 Vol: 122 Nbr: 3 Pgs: 637-45
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Akt inhibitors in clinical development for the treatment of cancer.
  Periodical: Expert Opinion on Investigational Drugs
  Author(s): Pal SK, Reckamp K, Yu H, Figlin RA
  Yr: 2010 Vol: Sept Nbr: Pgs: ePub
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Deciphering the anticancer mechanisms of sunitinib.
  Periodical: Cancer Biology and Therapy
  Author(s): Pal SK, Figlin RA, Yu H
  Yr: 2010 Vol: 10 Nbr: 7 Pgs: ePub
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors.
  Periodical: Clinical Medicine Insights: Oncology
  Author(s): Pal SK, Figlin RA
  Yr: 2010 Vol: 4 Nbr: Pgs: 43-53
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Cognitive changes associated with endocrine therapy for breast cancer.
  Periodical: Maturitas
  Author(s): Agrawal K, Onami S, Mortimer JE, Pal SK
  Yr: 2010 Vol: Aug Nbr: Pgs: ePub
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Targeted therapies: Pazopanib: carving a niche in a crowded therapeutic landscape.
  Periodical: Nature Revieww, Clinical Oncology
  Author(s): Pal SK, Figlin RA
  Yr: 2010 Vol: 7 Nbr: 7 Pgs: 362-3
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer
 
Targeted therapies for non-small cell lung cancer: an evolving landscape.
  Periodical: Molecular Cancer Therapeutics
  Author(s): Pal SK, Figlin RA, Reckamp K
  Yr: 2010 Vol: 9 Nbr: 7 Pgs: 1931-44
  Associated Grant: Survival in de novo and Recurrent Metastatic Breast Cancer